GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (TSE:7733) » Definitions » Cyclically Adjusted PS Ratio

Olympus (TSE:7733) Cyclically Adjusted PS Ratio : 2.48 (As of Jul. 19, 2025)


View and export this data going back to 1949. Start your Free Trial

What is Olympus Cyclically Adjusted PS Ratio?

As of today (2025-07-19), Olympus's current share price is 円1721.00. Olympus's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was 円693.87. Olympus's Cyclically Adjusted PS Ratio for today is 2.48.

The historical rank and industry rank for Olympus's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:7733' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.12   Med: 2.98   Max: 5.19
Current: 2.48

During the past years, Olympus's highest Cyclically Adjusted PS Ratio was 5.19. The lowest was 1.12. And the median was 2.98.

TSE:7733's Cyclically Adjusted PS Ratio is ranked worse than
50.83% of 482 companies
in the Medical Devices & Instruments industry
Industry Median: 2.325 vs TSE:7733: 2.48

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Olympus's adjusted revenue per share data for the three months ended in Mar. 2025 was 円237.356. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円693.87 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Olympus Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Olympus's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Cyclically Adjusted PS Ratio Chart

Olympus Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.73 3.91 3.78 3.43 2.81

Olympus Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.43 3.94 4.07 3.46 2.81

Competitive Comparison of Olympus's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Olympus's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Olympus's Cyclically Adjusted PS Ratio falls into.


;
;

Olympus Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Olympus's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1721.00/693.87
=2.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olympus's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Olympus's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=237.356/111.1000*111.1000
=237.356

Current CPI (Mar. 2025) = 111.1000.

Olympus Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 136.974 98.400 154.653
201509 152.037 98.500 171.485
201512 143.700 98.100 162.743
201603 154.842 97.900 175.720
201606 123.134 98.100 139.451
201609 131.516 98.000 149.096
201612 133.659 98.400 150.910
201703 152.446 98.100 172.648
201706 125.476 98.500 141.527
201709 144.265 98.800 162.225
201712 147.989 99.400 165.408
201803 156.901 99.200 175.723
201806 132.217 99.200 148.078
201809 147.325 99.900 163.842
201812 145.789 99.700 162.459
201903 155.759 99.700 173.569
201906 133.126 99.800 148.199
201909 149.711 100.100 166.163
201912 150.013 100.500 165.835
202003 150.756 100.300 166.989
202006 106.295 99.900 118.212
202009 139.826 99.900 155.502
202012 153.224 99.300 171.432
202103 168.677 99.900 187.588
202106 148.896 99.500 166.255
202109 150.264 100.100 166.777
202112 145.486 100.100 161.473
202203 159.087 101.100 174.823
202206 150.942 101.800 164.731
202209 176.351 103.100 190.035
202212 176.855 104.100 188.747
202303 191.412 104.400 203.696
202306 165.361 105.200 174.635
202309 183.423 106.200 191.886
202312 199.744 106.800 207.786
202403 213.079 107.200 220.831
202406 201.119 108.200 206.509
202409 207.042 108.900 211.225
202412 221.716 110.700 222.517
202503 237.356 111.100 237.356

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Olympus  (TSE:7733) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Olympus Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Olympus's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.

Olympus Headlines

No Headlines